Literature DB >> 29019060

Reports of three cases with the initial presentation of mesenteric vasculitis in children with system lupus erythematous.

Yuan Liu1, Jia Zhu1, Jian Ming Lai2, Xue Feng Sun3, Jun Hou1, Zhi Xuan Zhou1, Xin Yu Yuan3.   

Abstract

We reviewed three cases of systemic lupus erythematosus (SLE) in children with mesenteric vasculitis (LMV) as initial presentation and analysed their clinical characteristics to improve the understanding of this disease. Three patients with SLE were admitted to our hospital and initially presented with gastrointestinal symptoms. We retrospectively analysed their clinical data, including clinical presentations, laboratory results, images and short- and long-term treatment outcomes. (1) All three children were school-age girls. The patients were presented to our hospital with vomiting and abdominal pain as initial symptoms. The patients also had urinary symptoms, including proteinuria in three cases, ureteropelvic dilatation in two cases and hydronephrosis in one case. (2) The patients had various positive autoantibodies and a low complement level. Two of the patients had blood system involvement, and one had central nervous system symptoms. (3) All of the patients had active SLE (SLEDAI-2K score ≥ 5 points and moderate to severe degree 10-24). (4) Abdominal CT scans with contrast showed the 'target sign' of the intestinal wall in case 1, a slightly thickened intestinal wall and blurry mesentery in case 2, and the 'comb sign' of the margin mesenteric blood vessels in case 3. (5) All three patients responded promptly to steroid therapy. The patients' symptoms improved rapidly after treatment. LMV is a rare SLE complication. The lack of comprehensive understanding of LMV's clinical presentation makes it considerably challenging to diagnose. LMV is also a serious complication of SLE that is often accompanied by concurrent damage to other organs. LMV often occurs with active SLE but responds rapidly to glucocorticoid therapy. Therefore, in order to make early diagnosis and treatment, we suggest checking autoantibodies and abdominal CT scans with contrast when children present with gastrointestinal symptoms and the involvement of other organs, especially the urinary system.

Entities:  

Keywords:  Childhood-onset systemic lupus erythematosus; Gastrointestinal manifestations; Lupus mesenteric vasculitis

Mesh:

Year:  2017        PMID: 29019060     DOI: 10.1007/s10067-017-3841-0

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  14 in total

1.  Lupus the great mimic: gastrointestinal manifestations.

Authors:  H H Chng
Journal:  Singapore Med J       Date:  2001-08       Impact factor: 1.858

2.  Abdominal manifestations in childhood-onset systemic lupus erythematosus.

Authors:  O Richer; T Ulinski; I Lemelle; B Ranchin; C Loirat; J C Piette; P Pillet; P Quartier; R Salomon; B Bader-Meunier
Journal:  Ann Rheum Dis       Date:  2006-07-03       Impact factor: 19.103

3.  Lupus mesenteric vasculitis: clinical features and associated factors for the recurrence and prognosis of disease.

Authors:  Shiwen Yuan; Yujin Ye; Dongying Chen; Qian Qiu; Zhongping Zhan; Fan Lian; Hao Li; Liuqin Liang; Hanshi Xu; Xiuyan Yang
Journal:  Semin Arthritis Rheum       Date:  2013-11-12       Impact factor: 5.532

4.  CT features of systemic lupus erythematosus in patients with acute abdominal pain: emphasis on ischemic bowel disease.

Authors:  J Y Byun; H K Ha; S Y Yu; J K Min; S H Park; H Y Kim; K A Chun; K H Choi; B H Ko; K S Shinn
Journal:  Radiology       Date:  1999-04       Impact factor: 11.105

Review 5.  Intestinal pseudo-obstruction in systemic lupus erythematosus: an uncommon but important clinical manifestation.

Authors:  M Y Mok; R W Wong; C S Lau
Journal:  Lupus       Date:  2000       Impact factor: 2.911

6.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

Authors:  Michelle Petri; Ana-Maria Orbai; Graciela S Alarcón; Caroline Gordon; Joan T Merrill; Paul R Fortin; Ian N Bruce; David Isenberg; Daniel J Wallace; Ola Nived; Gunnar Sturfelt; Rosalind Ramsey-Goldman; Sang-Cheol Bae; John G Hanly; Jorge Sánchez-Guerrero; Ann Clarke; Cynthia Aranow; Susan Manzi; Murray Urowitz; Dafna Gladman; Kenneth Kalunian; Melissa Costner; Victoria P Werth; Asad Zoma; Sasha Bernatsky; Guillermo Ruiz-Irastorza; Munther A Khamashta; Soren Jacobsen; Jill P Buyon; Peter Maddison; Mary Anne Dooley; Ronald F van Vollenhoven; Ellen Ginzler; Thomas Stoll; Christine Peschken; Joseph L Jorizzo; Jeffrey P Callen; S Sam Lim; Barri J Fessler; Murat Inanc; Diane L Kamen; Anisur Rahman; Kristjan Steinsson; Andrew G Franks; Lisa Sigler; Suhail Hameed; Hong Fang; Ngoc Pham; Robin Brey; Michael H Weisman; Gerald McGwin; Laurence S Magder
Journal:  Arthritis Rheum       Date:  2012-08

7.  Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy.

Authors:  P A Hill; K M Dwyer; D A Power
Journal:  Lupus       Date:  2000       Impact factor: 2.911

8.  Differences in disease features between childhood-onset and adult-onset systemic lupus erythematosus patients presenting with acute abdominal pain.

Authors:  Yu-Ling Tu; Kuo-Wei Yeh; Li-Chen Chen; Tsung-Chieh Yao; Liang-Shiou Ou; Wen-I Lee; Jing-Long Huang
Journal:  Semin Arthritis Rheum       Date:  2010-09-29       Impact factor: 5.532

9.  Systemic lupus erythematosus disease activity index 2000.

Authors:  Dafna D Gladman; Dominique Ibañez; Murray B Urowitz
Journal:  J Rheumatol       Date:  2002-02       Impact factor: 4.666

10.  Lupus enteritis: clinical characteristics, risk factor for relapse and association with anti-endothelial cell antibody.

Authors:  S-K Kwok; S-H Seo; J H Ju; K-S Park; C-H Yoon; W-U Kim; J-K Min; S-H Park; C-S Cho; H-Y Kim
Journal:  Lupus       Date:  2007       Impact factor: 2.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.